Exploring the impact of nucleotide length on lipid nanoparticle structure and properties

Read full text
Authors: Michal Hammel, Yuchen Fan, Lee Joon Kim, Nanzhi Zang, Baixue Xiao, Antonino Calio, Chun‐Wan Yen, Greg L. Hura
Cited by: 0
References: 52

Abstract

Lipid nanoparticles (LNPs) are versatile carriers for nucleic acid (NA) therapeutics, including ASOs, siRNA, mRNA, and poly-IC. While lipid composition is known to influence LNP properties, the impact of NA length on morphology and internal structure is less understood, particularly during the stages of carrier–cargo assembly. Here, we examine NA length and lipid composition immediately after mixing using high-throughput SAXS, dynamic light scattering, and cryogenic electron microscopy. All LNPs form ordered NA/lipid compartments, with longer NAs promoting inverse hexagonal (HII) phases and larger intercompartment distances. In contrast, short NAs, especially in SM102 formulations, favor lamellar phases. SAXS peak deconvolution quantifies ordered versus disordered phases via a Phase Quality Factor (Q-factor), which correlates with particle size and encapsulation efficiency. MC3/DOPE formulations exhibit the most stable HII-phase packing, highlighting the role of helper-lipid curvature in compartment stabilization. Variations in NA compartmentalization indicate differences in payload capacity, offering a framework for rational LNP design across diverse nucleic acid cargos.

Fields of Study & Subjects

RNA Interference and Gene Delivery Lipid Membrane Structure and Behavior Advancements in Transdermal Drug Delivery

Publication details

Journal / source
International Journal of Pharmaceutics
Publisher
Elsevier BV
Volume
698
Pages
126944–126944
Publication date
1 May 2026
Language
EN